哈萨克斯坦 2015 至 2021 年可避免死亡率趋势。

IF 3.1 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES International Journal of Health Policy and Management Pub Date : 2024-02-17 DOI:10.34172/ijhpm.2024.7919
Lyazzat Kosherbayeva, Nazgul Akhtayeva, Kamshat Tolganbayeva, Aizhan Samambayeva
{"title":"哈萨克斯坦 2015 至 2021 年可避免死亡率趋势。","authors":"Lyazzat Kosherbayeva, Nazgul Akhtayeva, Kamshat Tolganbayeva, Aizhan Samambayeva","doi":"10.34172/ijhpm.2024.7919","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The health system performance assessment is a challenging process for decision-makers. In case of Kazakhstan's healthcare system, the calculation of avoidable mortality, which has been underutilized to date, could serve as an additional tool to prioritize areas for improvement. Therefore, the aim of the study is to analyse avoidable mortality in Kazakhstan.</p><p><strong>Methods: </strong>The data was retrieved from the Bureau of National Statistics, Kazakhstan. It covers population data by age, mortality rates from disease groups based on the Joint OECD/Eurostat classification of preventable and treatable causes of mortality. The data spans from 2015 to 2021, categorized by gender and 5-year age groups (0, 1-4, 5-9, ..., 70-74). Standardization was performed using the 2015 OECD standard population. We used joinpoint regression analysis to calculate the average annual percentage change.</p><p><strong>Results: </strong>From 2015 to 2019, the annual percentage change in avoidable mortality per 100000 population was -3.8 (-5.7 to -1.8), and from 2019 to 2021 it increased by 17.6 (11.3 to 24.3). Males exhibited higher avoidable mortality rates compared to females. The preventable mortality rate was consistently higher than the treatable mortality. Both preventable and treatable mortality decreased from 2015 to 2019, with preventable mortality reaching 272.17 before rising to 379.23 per 100000 population in 2021. Between 2015 and 2021, treatable mortality rates increased from 179.3 (176.93- 181.67) to 205.45 (203.08-207.81) per 100000 population.</p><p><strong>Conclusion: </strong>In Kazakhstan, the leading causes of avoidable mortality were circulatory diseases, respiratory diseases, and cancer. To achieve the goals of Universal Health Coverage and improve the overall population health, there is an urgent need to amend the healthcare system and reduce avoidable mortality. While it is important to acknowledge the influence of COVID-19 on these trends, our study's focus on avoidable mortality provides valuable insights that complement the understanding of pandemic-related effects.</p>","PeriodicalId":14135,"journal":{"name":"International Journal of Health Policy and Management","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2024-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Trends in Avoidable Mortality in Kazakhstan From 2015 to 2021.\",\"authors\":\"Lyazzat Kosherbayeva, Nazgul Akhtayeva, Kamshat Tolganbayeva, Aizhan Samambayeva\",\"doi\":\"10.34172/ijhpm.2024.7919\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The health system performance assessment is a challenging process for decision-makers. In case of Kazakhstan's healthcare system, the calculation of avoidable mortality, which has been underutilized to date, could serve as an additional tool to prioritize areas for improvement. Therefore, the aim of the study is to analyse avoidable mortality in Kazakhstan.</p><p><strong>Methods: </strong>The data was retrieved from the Bureau of National Statistics, Kazakhstan. It covers population data by age, mortality rates from disease groups based on the Joint OECD/Eurostat classification of preventable and treatable causes of mortality. The data spans from 2015 to 2021, categorized by gender and 5-year age groups (0, 1-4, 5-9, ..., 70-74). Standardization was performed using the 2015 OECD standard population. We used joinpoint regression analysis to calculate the average annual percentage change.</p><p><strong>Results: </strong>From 2015 to 2019, the annual percentage change in avoidable mortality per 100000 population was -3.8 (-5.7 to -1.8), and from 2019 to 2021 it increased by 17.6 (11.3 to 24.3). Males exhibited higher avoidable mortality rates compared to females. The preventable mortality rate was consistently higher than the treatable mortality. Both preventable and treatable mortality decreased from 2015 to 2019, with preventable mortality reaching 272.17 before rising to 379.23 per 100000 population in 2021. Between 2015 and 2021, treatable mortality rates increased from 179.3 (176.93- 181.67) to 205.45 (203.08-207.81) per 100000 population.</p><p><strong>Conclusion: </strong>In Kazakhstan, the leading causes of avoidable mortality were circulatory diseases, respiratory diseases, and cancer. To achieve the goals of Universal Health Coverage and improve the overall population health, there is an urgent need to amend the healthcare system and reduce avoidable mortality. While it is important to acknowledge the influence of COVID-19 on these trends, our study's focus on avoidable mortality provides valuable insights that complement the understanding of pandemic-related effects.</p>\",\"PeriodicalId\":14135,\"journal\":{\"name\":\"International Journal of Health Policy and Management\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2024-02-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Health Policy and Management\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.34172/ijhpm.2024.7919\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Health Policy and Management","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.34172/ijhpm.2024.7919","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

摘要

背景:对决策者而言,医疗系统绩效评估是一项具有挑战性的工作。就哈萨克斯坦的医疗保健系统而言,可避免死亡率的计算迄今为止一直未得到充分利用,它可以作为一种额外的工具,优先考虑需要改进的领域。因此,本研究旨在分析哈萨克斯坦可避免的死亡率:数据取自哈萨克斯坦国家统计局。数据包括按年龄划分的人口数据、根据经合组织/欧盟统计局对可预防和可治疗的死亡原因的联合分类得出的疾病组死亡率。数据时间跨度为 2015 年至 2021 年,按性别和 5 岁年龄组(0、1-4、5-9、......、70-74)分类。采用 2015 年经合组织标准人口进行标准化。我们使用连接点回归分析来计算年均百分比变化:结果:从 2015 年到 2019 年,每 10 万人可避免死亡率的年百分比变化为-3.8(-5.7 到-1.8),从 2019 年到 2021 年增加了 17.6(11.3 到 24.3)。与女性相比,男性的可避免死亡率更高。可预防死亡率一直高于可治疗死亡率。从 2015 年到 2019 年,可预防死亡率和可治疗死亡率均有所下降,可预防死亡率为每 10 万人 272.17 例,到 2021 年上升到 379.23 例。在 2015 年至 2021 年期间,可治疗死亡率从每 10 万人 179.3(176.93-181.67)上升到 205.45(203.08-207.81):在哈萨克斯坦,可避免死亡的主要原因是循环系统疾病、呼吸系统疾病和癌症。为了实现全民医保的目标和改善总体人口健康状况,迫切需要修正医疗保健系统和降低可避免的死亡率。虽然承认 COVID-19 对这些趋势的影响很重要,但我们的研究侧重于可避免的死亡率,这提供了宝贵的见解,补充了对大流行相关影响的理解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Trends in Avoidable Mortality in Kazakhstan From 2015 to 2021.

Background: The health system performance assessment is a challenging process for decision-makers. In case of Kazakhstan's healthcare system, the calculation of avoidable mortality, which has been underutilized to date, could serve as an additional tool to prioritize areas for improvement. Therefore, the aim of the study is to analyse avoidable mortality in Kazakhstan.

Methods: The data was retrieved from the Bureau of National Statistics, Kazakhstan. It covers population data by age, mortality rates from disease groups based on the Joint OECD/Eurostat classification of preventable and treatable causes of mortality. The data spans from 2015 to 2021, categorized by gender and 5-year age groups (0, 1-4, 5-9, ..., 70-74). Standardization was performed using the 2015 OECD standard population. We used joinpoint regression analysis to calculate the average annual percentage change.

Results: From 2015 to 2019, the annual percentage change in avoidable mortality per 100000 population was -3.8 (-5.7 to -1.8), and from 2019 to 2021 it increased by 17.6 (11.3 to 24.3). Males exhibited higher avoidable mortality rates compared to females. The preventable mortality rate was consistently higher than the treatable mortality. Both preventable and treatable mortality decreased from 2015 to 2019, with preventable mortality reaching 272.17 before rising to 379.23 per 100000 population in 2021. Between 2015 and 2021, treatable mortality rates increased from 179.3 (176.93- 181.67) to 205.45 (203.08-207.81) per 100000 population.

Conclusion: In Kazakhstan, the leading causes of avoidable mortality were circulatory diseases, respiratory diseases, and cancer. To achieve the goals of Universal Health Coverage and improve the overall population health, there is an urgent need to amend the healthcare system and reduce avoidable mortality. While it is important to acknowledge the influence of COVID-19 on these trends, our study's focus on avoidable mortality provides valuable insights that complement the understanding of pandemic-related effects.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
International Journal of Health Policy and Management
International Journal of Health Policy and Management Health Professions-Health Information Management
CiteScore
5.40
自引率
14.30%
发文量
142
审稿时长
9 weeks
期刊介绍: International Journal of Health Policy and Management (IJHPM) is a monthly open access, peer-reviewed journal which serves as an international and interdisciplinary setting for the dissemination of health policy and management research. It brings together individual specialties from different fields, notably health management/policy/economics, epidemiology, social/public policy, and philosophy into a dynamic academic mix.
期刊最新文献
Why Are African Researchers Left Behind in Global Scientific Publications? - A Viewpoint. Grappling With the Inclusion of Patients and the Public in Consensus Building: A Commentary on Inclusion, Safety, and Accessibility; Comment on "Evaluating Public Participation in a Deliberative Dialogue: A Single Case Study". Phase IV Drug Trials With a Canadian Site: A Comparison of Industry and Non-Industry-Funded Trials. The Rhetoric of Decolonizing Global Health Fails to Address the Reality of Settler Colonialism. Gaza as a Case in Point. Building a Systems Map: Applying Systems Thinking to Unhealthy Commodity Industry Influence on Public Health Policy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1